New insights in outcome after major trauma by Nijboer, Johanna Maria Margaretha
  
 University of Groningen
New insights in outcome after major trauma
Nijboer, Johanna Maria Margaretha
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2009
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Nijboer, J. M. M. (2009). New insights in outcome after major trauma. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
HYPERGLYCEMIA HAS A 
STRONGER RELATION WITH 
OUTCOME IN TRAUMA 













Acute hyperglycemia is associated with adverse outcome in critically ill patients. Glucose 
control with insulin improves outcome in surgical intensive care unit (SICU) patients, but 
the effect in trauma patients is unknown. We investigated hyperglycemia and outcome 
in SICU patients with and without trauma.
Methods 
A 12-year retrospective study was performed at a 12-bed SICU. We collected the reason for 
admission, Injury Severity Scores (ISS), and 30-day mortality rates. Glucose measurements 
were used to calculate the hyperglycemic index (HGI), a measure indicative of overall 
hyperglycemia during the entire SICU stay.
Results 
In all, 5234 nontrauma and 865 trauma patients were studied. Trauma patients were 
younger, more frequently male, and had both lower median admission glucose (123 
versus 133 mg/dL) and HGI levels (8.9 vs. 18.4 mg/dL) than nontrauma patients (p < 
0.001). Mortality was 12% in both groups. Area under the receiver-operator characteristic 
for HGI and mortality was 0.76 for trauma patients and 0.58 for nontrauma patients (p 
< 0.001). In multivariate analysis, HGI correlated better with mortality in trauma patients 
than in nontrauma patients (p < 0.001). Head-injury and nonhead-injury trauma patients 
showed similar glucose levels and relation between glucose and mortality.
Conclusions
The relation of hyperglycemia and mortality is more pronounced in trauma patients than 
in SICU patients admitted for other reasons. The different behavior of hyperglycemia in 




Acute hyperglycemia caused by acute disease is associated with adverse outcome. This 
association has been demonstrated in patients suffering from trauma1–3, myocardial 
infarction4, and stroke5, as for both general ICU patients6 and patients admitted to the 
hospital ward7. Numerous reports have documented the relation of early hyperglycemia 
with outcome in trauma patients8–16. Numerous studies have concentrated on early 
hyperglycemia (i.e., hyperglycemia at admission or during the first 24 hours) in head injury 
patients. Although glucose levels after the first day have been studied in conjunction with 
hormone levels or with age17–20, their relation with outcome has not been previously 
extensively studied, as all prior studies included less than 50 patients. Similarly, although 
some investigators have compared hormonal levels in trauma patients with and without 
head injury18,20,  no study compared the association between hyperglycemia and 
outcome directly in these two patient groups. Two intervention studies have showed 
improvement in outcome after strict treatment of hyperglycemia in the intensive care 
unit21,22. However, trauma patients only made up 4.4%21 and 5.4%22 of the study 
subjects and therefore the effect of this intervention on trauma patients remains unclear. 
To elucidate the possible value of intensive insulin therapy in trauma patients, we 
performed a retrospective study to analyze how changes in glucose relate to mortality 
in subgroups of ICU patients with various reasons for admission, focusing especially on 
differences between trauma patients and nontrauma patients. To assess overall glucose 
control during a longer period than 1 or 2 days, we have developed the hyperglycemic 
index (HGI). HGI is calculated from all the glucose measurements taken during the entire 
length of stay at the ICU for a single patient23. In contrast to admission glucose, HGI 
reflects hyperglycemia that is amenable to insulin therapy. Within the trauma group, we 
also analyzed the difference between patients with and patients without head injury.
MATERIALS AND METHODS
Patients and Treatment
Our study retrospectively analyzed all patients over 15 years of age admitted from 1990 
through 2001 to the surgical intensive care unit (SICU) of the Groningen University 
Hospital, a tertiary teaching hospital and Level I trauma center. Patients with no glucose 
measurements were excluded. Enteral nutrition was started as soon as possible after 
admission, whereas parenteral nutrition was infrequently used. Insulin treatment was 
conservative, as insulin administration was only started when glucose levels reached 
180 mg/dL; insulin was never administered above 10 IU/h. Except for liver transplant 







Age, sex, reason for admission and all glucose measurements taken during the ICU stay 
were retrieved from the central hospital information database. The Injury Severity Score 
(ISS)24 as well as International Classification of Diseases (ICD)-9 codes were recorded for 
trauma patients. ICD diagnoses for closed or penetrating skull or cerebral injuries were 
used to categorize these patients as suffering from head injury or not. Admission glucose 
was defined as the first glucose measurement upon arrival at the ICU. See Vogelzang 
et al.23 for the exact calculation of HGI. The hyperglycaemic index corrects for irregular 
sampling intervals and is not erroneously lowered by hypoglycemic episodes, as HGI only 
measures levels higher than 108 mg/dL (6.0 mmol/L). HGI can be viewed as the mean 
glucose level above 108 mg/dL. Therefore, the HGI yields a better estimate of overall 
glucose control than a single value at admission or the highest value during the first day. 
Mean glucose levels of all patients were calculated at fixed intervals of 12 hours after 
admission by linearly interpolating glucose measurements. Hypoglycemia was defined as 
a measurement lower than 54 mg/dL (3.0 mmol/L). The primary endpoint of this study 
was 30-day mortality.
Statistical analysis
Data are presented as medians and interquartile range (IQR) for both continuous and 
ordinal variables. When comparing groups, Student’s t test, the Mann-Whitney U 
test, or Fisher’s exact test were used when appropriate. Univariate analysis of glucose 
parameters and mortality was performed by calculating receiver-operator characteristics 
(ROC) curves. Multivariate analysis was performed by means of binary logistic regression 
that controlled for age, sex, and ISS (for trauma patients). All evaluated parameters were 
entered in the model. Odds ratios for glucose-related parameters were calculated for 
increases of 10 mg/dL. Significance of differences between odds ratios was calculated 
as described by Altman and Bland25. Statistics were performed with the SPSS statistical 
package (version 10.0.7, SPSS Inc, Chicago, IL) and Excel (version 97-SR 2, Microsoft 
Corporation. Redmond, WA).
RESULTS
During the study period, 6,099 out of 6,307 admissions (97%) met the inclusion criteria. 
Overall mortality was 12%. The reasons for admission were trauma (N = 865, mortality 
12.4%), abdominal surgery (N = 2256, mortality 10.8%), liver transplantation (N = 552, 
mortality 9.1%), vascular surgery (N = 921, mortality 13.5%), and miscellaneous (N = 
1505, mortality 14.2%). As trauma patients were the focus of our study, and as univariate 
correlation between hyperglycemia and outcome was similar for all nontrauma groups 
(see Fig. 2), we will present only differences between trauma patients and nontrauma 
patients. 
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Trauma patients significantly differed from those without trauma in several demographics: 
age, length of stay, admission glucose, and HGI (all p < 0.001, Table 1). The median 
(IQR) ISS for all trauma patients was 21 (13 – 29). Hypoglycemia occurred in 14 trauma 
patients (1.6%) and in 190 patients without trauma (3.5%, p = 0.001). Of the trauma 
patients, 402 (46%) had head injury. Patients with head injury were younger, had higher 
ISS scores, and stayed longer at the ICU, and died of different causes than those without 
head injury (Table 2). Mortality in patients without head injury was 11% compared with 
14% in patients with head injury (p = 0.01).
Figure 1, A and B shows mean glucose levels from admission to 5 days after admission 
for patients with and without trauma. As demonstrated by HGI levels in Table 1, 
patients without trauma had higher overall mean glucose levels than trauma patients. 
Figure 1. Mean glucose level from 
admission to 5 days after admission 
for survivors (continuous line, filled 
symbols) and non-survivors (dotted 
line, empty symbols) of non-trauma 
patients and trauma patients. 
The error bars depict 1 standard 
error of the mean. Stars denote a 
significant difference (p < 0.05) after 
Bonferroni’s correctionfor multiple 
testing. The shaded area represents 







Nonsurvivors displayed higher glucose values than survivors in the trauma group as well 
as in the group with other conditions (Figure 1). Moreover, the trauma group showed a 
greater difference in mean glucose levels between survivors and nonsurvivors than the 
nontrauma group. A selection effect could play a role in this kind of figure as a large 
number of patients left the ICU during the first 5 days. However, the same analysis of 
patients who stayed 5 days or longer displayed a similar pattern. 
Figure 2 shows ROC curves of HGI and mortality in all subgroups. The area under 
the curve for nontrauma patients was low (0.56 for abdominal surgery, 0.61 for liver 
transplantation, 0.62 for vascular surgery, and 0.57 for miscellaneous). All nontrauma 
groups together had an area under the curve of 0.58 versus 0.76 for trauma patients (p 
< 0.001). For head injury patients, the area under the ROC was 0.79 and trauma patients 
without head injury had an area of 0.72 (p = 0.20). The area under the curve for HGI was 
Table 1. General characteristics of patients studied
Nontrauma Trauma P-value
N 5234 865
Male N (%) 3204 (61) 642 (74) < 0.001
Mortality N (%) 631 (12) 107 (12) 0.78
Age (years)1 62 (49 – 71) 38 (25 – 57) < 0.001
Length of stay (days)1 1.6 (0.9 – 4.6) 2.6 (1.1 – 7.5) < 0.001
Number of glucose measurements / day1 2.3 (1.7 – 3.6) 1.7 (1.3 – 2.6) < 0.001
Admission glucose (mg/dL)1 133 (106 – 171) 123 (103 – 151) < 0.001
Hyperglycemic index (mg/dL)1 18.4 (4.6 – 44.2) 8.9 (1.8 – 26.5) < 0.001
1 median (interquartile range)
Figure 2. Receiver-operator characteristics 
for 30-day mortality and Hyperglycemic index 
in ICU patients with different reasons for 
admission, Areas under the curve are 0.76 for 
trauma, 0.56 for abdominal surgery, 0.61 for 
liver transplant, 0.62 for vascular surgery and 
0.57 for miscellaneous.
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bigger compared with admission glucose in all subgroups. The area under the ROC for 
ISS in all trauma patients was 0.66. 
Multivariate analysis revealed that HGI correlated significantly better with mortality in 
patients with trauma than in patients without trauma (Table 3, p < 0.001). Of admission 
glucose and HGI, only HGI is a significant parameter in the multivariate model (p < 0.001). 
Further analysis of the trauma group showed no significant differences in odds ratios of 
measured variables between head injury and non-head injury patients, apart from age, 
for which the odds ratio (95% confidence interval) was 1.01 (1.00 – 1.03) in head injury 
patients and 1.05 (1.03 – 1.07) in patients without head injury (p = 0.006).
Table 2. Characteristics of trauma patients with and without head injury
Non-head injury Head injury P-value
N 463 402
Male sex N (%) 327 (71) 315 (78) 0.10
Mortality N (%) 49 (11) 58 (14) 0.01
Age (years)1 42 (27 – 68) 32 (23 – 50) < 0.001
Length of stay (days)1 2.1 (1.0 – 6.3) 3.0 (1.5 – 10.0) < 0.001
Admission glucose (mg/dL)1 119 (101 – 150) 124 (104 – 155) 0.07
Hyperglycemic index (mg/dL)1 8.2 (1.12 – 2.7) 9.8 (2.4 – 29.0) 0.02
Injury Severity Score1 16 (9 – 25) 25 (18 – 34) < 0.001
Cause of death N (%)
Neurological 9 (18) 46 (79)
Circulatory failure 19 (39) 6 (10)
Respiratory failure 5 (10) 3 (5) < 0.001
Sepsis/multiple organ failure 12 (24) 1 (2)
Pulmonary embolism 2 (4) 1 (2)
Unknown 2 (4) 1 (2)
1 median (interquartile range)







Age 1.03 (1.02 – 1.04)* 1.03 (1.02 – 1.04)* 0.74
Male 1.16 (0.97 – 1.38) 0.96 (0.57 – 1.61) 0.49
Admission glucose (per increase of 10 mg/dL) 0.99 (0.97 – 1.00) 0.98 (0.89 – 1.08) 0.99
Hyperglycemic index (per increase of 10 mg/dL) 1.10 (1.07 – 1.13)* 1.46 (1.29 – 1.65)* < 0.001
Injury Severity Score - 1.09 (1.07 – 1.12)*








The relation between hyperglycemia and outcome depended upon reason of admission 
and was stronger in trauma patients than in other types of critically ill patients, regardless 
of the presence of head injury. Nonsurviving trauma patients showed marked early 
hyperglycemia, whereas surviving trauma patients sustained only minor hyperglycemia. 
Remarkably, glucose levels and their relation with outcome were similar in trauma patients 
with and without head injury. The hyperglycemic index was superior to admission glucose 
in discriminating survivors and nonsurvivors in all subgroups. 
It must be noted that this study was conducted at an SICU and not at an emergency 
department. Therefore, patients might already have undergone surgery or other therapy 
before the admission glucose level was recorded. This may explain why admission 
glucose and ISS were not as strongly correlated with outcome as in studies that utilize 
glucose levels from the emergency department2,9,10,12–16. However, this does not affect 
the relevance of this study, as intensive insulin therapy is mostly advocated while patients 
are treated at an ICU. Another limitation is that we did not include confounding factors 
such as caloric intake, steroid use, history of diabetes, and insulin use. 
Injury-induced hyperglycemia was already recognized by Claude Bernard. Injury causes 
an immediate surge of catecholamines in the blood26. The stress response to trauma 
or surgery causes a hypermetabolic state, characterized by protein and fat catabolism, 
negative nitrogen balance, hyperglycemia, and insulin resistance27,28. Although 
peripheral uptake of glucose as well as cellular glucose utilization is enhanced, increased 
gluconeogenesis and insulin resistance may prevail, leading to hyperglycemia29. The 
stress response provides a plausible link between injury and the rise in glucose. Glucose 
levels have been shown to correlate with catecholamine levels in general trauma patients 
and patients with head injury12,18,20,26. 
Previously a causal relation has been suggested between glucose and outcome in head 
injury patients. Assuming hyperglycemia increases anaerobic metabolism and subsequently 
higher intracerebral lactate levels, low pH levels causing secondary brain damage may 
result9–14. However, De Salles and colleagues have found that cerebrospinal fluid lactate 
levels stayed high for more than 5 days after trauma, when blood glucose had already 
normalized30, obscuring a direct relation. Recently, Diaz-Parejo and colleagues have 
measured intracerebral lactate levels during both normoglycemia and hyperglycemia. 
They found that intracerebral lactate concentration only increased when blood glucose 
values were over 270 mg/dL, and thus is less likely to play a role at more modest levels 
of hyperglycemia31. Our finding of similarity in the relation between hyperglycemia 
and mortality in head injury and non-head injury patients could also indicate that other 
mechanisms, common to both patient groups, are present. 
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We think the notably different glucose profiles of trauma patients and other ICU 
patients can be explained by their different baseline characteristics. Trauma patients 
are significantly younger than other ICU patients and suffer only from trauma, whereas 
general ICU patients are often older, and more often than not suffer from multiple 
conditions. Injury drives the stress response, and young trauma patients are able to 
build up a powerful reaction. Therefore, hyperglycemia might reflect severity of illness 
better in trauma patients than in general ICU patients. Previous investigators have found 
that adding additional severity of illness scores into their multivariate model diminishes 
the role of glucose in predicting outcome9,11. Whether the strong correlation between 
hyperglycemia and outcome is caused by confounding factors like severity of illness or 
by a causal relation cannot be concluded from this or any other retrospective study. We 
think that the differences found in this retrospective study justify the conclusion that 
regarding hyperglycemia, trauma patients differ from other ICU patients. Furthermore, 
even with our very conservative insulin protocol, surviving trauma patients only had very 
modest hyperglycemia as shown in Figure 1 and reflected in their HGI of only 9 mg/dL, 
which is equivalent to a mean glucose level of 117 mg/dL. 
Thorell and colleagues recently investigated how intensive insulin therapy leads to 
normoglycemia in critically ill trauma patients. They showed that insulin reduces 
endogenous glucose production, whereas whole-body glucose disposal is not 
increased32. The mechanism behind the impressive results of intensive insulin therapy 
in the study by van den Berghe and colleagues is still largely unknown21. Multiple 
theories have been proposed, including a decreased infection rate due to improved 
macrophage function, reduced endothelial dysfunction, improvement of lipid disorders, 
and reduced hyperglycaemic axonal damage33. These general mechanisms may apply to 
every critically ill patient and, therefore, proponents advocate intensive insulin therapy 
in all critically ill patients, regardless of underlying illness34,35. However, retrospective 
data incompatible with this theory is available; Laird and colleagues did not find a 
significant relation between infection and hyperglycemic levels on day 1 or 2 in trauma 
patients3. Yendamuri and colleagues did find a significant relation between admission 
glucose and urinary tract infection and a borderline significant trend toward increased 
incidence of pneumonia, but no increased rate of bacteremia or wound infection2. 
More important, few trauma patients were included in the two intervention studies that 
actually implemented strict glucose control by intensive insulin therapy. In the Leuven 
study (a randomized controlled trial), the mortality in the trauma group was 8.6% in 
the conventional group (N = 35) and 12.1% in the intervention group (N = 33)21. In 
the study by Krinsley (a “before - after” study), the mortality rates were 17.8% and 
19.5%, respectively (N = 48 and 38)22. The trend toward higher mortality is remarkable 
regarding the Acute Physiology and Chronic Health Evaluation (APACHE-II) scores, which 








Our results show that trauma patients differ from patients with other reasons for 
admission. It is likely that different mechanisms play a role in glucose homeostasis in 
patient groups with different baseline characteristics. Caution is to be exercised when 
implementing insulin therapy in trauma patients. A randomized controlled trial in a large 
group of trauma patients is needed to bring the value of glucose control in trauma 
patients to light.
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